SCHEMBL26482177

SCHEMBL26482177

Oc1c(O)c(O)c(-c2ccc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4cccc5ccccc45)c3c2)c(O)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HSD17B1 P14061 2/20 0.41
▸ HSD17B2 P37059 2/20 0.41
▸ ESR2 Q92731 2/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ ACMSD Q8TDX5 1/20 0.40
▸ ALOX5 P09917 2/20 0.40
▸ SOS1 Q07889 2/20 0.39
▸ GPR84 Q9NQS5 1/20 0.37
▸ GSTP1 P09211 1/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26482173 1.00 HDAC4 (0.48) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL24960733 0.93 MCL1 (0.44) HDAC4HDAC2HDAC8MCL1ACMSD
SCHEMBL26482166 0.90 MCL1 (0.43) HDAC8HSD17B1HSD17B2ESR2ESR1
SCHEMBL26482175 0.89 MCL1 (0.43) HSD17B1HSD17B2ESR2ESR1MCL1
SCHEMBL26856185 0.88 PIM1 (0.41) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL26891939 0.88 PIM1 (0.41) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL24211489 0.88 PIM1 (0.44) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL536536 0.88 PIM1 (0.47) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL29350427 0.88 PIM1 (0.47) HDAC4HDAC2HDAC8HSD17B1HSD17B2
SCHEMBL15367037 0.87 PIM1 (0.43) HDAC4HDAC2HDAC8HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND PIEZO1, TMEM109, OXA1L HDAC4 4307/4885HDAC2 2885/4885HDAC8 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback